NCT06279351View on ClinicalTrials.gov

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 11, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Interventions
DRUG

Thalidomide+cetuximab+FOLFOX/FOLFIRI

Thalidomide+cetuximab+FOLFOX/FOLFIRI

Trial Locations (1)

400037

RECRUITING

the second affiliated hospital of Army medical university, Chongqing

All Listed Sponsors
collaborator

Chongqing Medical University

OTHER

lead

Xinqiao Hospital of Chongqing

OTHER